Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine

BACKGROUND: Bladder urothelial carcinoma (BLCA) is associated with high mortality and recurrence. Although mRNA-based vaccines are promising treatment strategies for combating multiple solid cancers, their efficacy against BLCA remains unclear. We aimed to identify potential effective antigens of BL...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zhuolun, Jing, Changying, Zhan, Hailun, Guo, Xudong, Suo, Ning, Kong, Feng, Tao, Wen, Xiao, Chutian, Hu, Daoyuan, Wang, Hanbo, Jiang, Shaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905425/
https://www.ncbi.nlm.nih.gov/pubmed/36761744
http://dx.doi.org/10.3389/fimmu.2023.1097472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905425/
https://www.ncbi.nlm.nih.gov/pubmed/36761744
http://dx.doi.org/10.3389/fimmu.2023.1097472

Ejemplares similares